The Latest Breaking News from FDA

This CEO is going to against the better judgment of the FDA to remain youthful.

Drug shortages in the US are forcing physicians and the public to scramble for access to vital medicines. While the problem isn’t new, the number of products in scarce supply is nearing an all-time high — and could get worse as generic drug makers pare back on the breadth of…

The FDA-licensed drug could be approved for use in the UK by the end of the year

The FDA’s updated food code, restaurants should have signs saying dogs are welcome and should develop plans to handle dogs and their waste. They should provide separate food bowls so dogs don’t use plates or utensils meant for humans.

Intentionally deadly bugs and toxins and misinformation are some key fears.

With abortion increasingly restricted in many states, Sen. Patty Murray (D-Wash.), hopes to persuade Republicans to back insurance coverage for over-the-counter birth control.

Millions of patients and their caregivers breathed a collective sigh of relief when drugmaker Eli Lilly recently announced its new experimental Alzheimer’s medication appears to slow cognitive decline by 35%. The Food and Drug Administration could approve the new treatment, donanemab, as soon as this year.

Letters: In all the domestic abuse cases where the CPS took no further action, it had made the right decision, says chief inspector Andrew T Cayley, while Duncan Woodhead of the FDA union also rejects claims of ‘cherrypicking’

Gene therapy has helped doctors make major strides in treating inherited blindness, and it's now being explored for other conditions.